Bispecifics Before CAR-T May Be Best-Bet Sequence for Large B-Cell Lymphoma

(MedPage Today) — The use of bispecific antibodies (BsAb) before chimeric antigen receptor T-cell therapy (CAR-T) appeared to be a more optimal treatment sequence than BsAb after CAR-T in patients with relapsed or refractory large B-cell lymphoma…

Source link : https://www.medpagetoday.com/hematologyoncology/lymphoma/119225

Author :

Publish date : 2025-12-30 21:30:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Bispecifics Before CAR-T May Be Best-Bet Sequence for Large B-Cell Lymphoma

In a Tumultuous Year, U.S. Health Policy Has Been Greatly Reshaped Under RFK Jr.

Liver Cancer Treatment Landscape Shifts Rapidly, but Best Sequencing Still Unclear

Related Posts

EPA Revokes Finding That Helped Fight Climate Change: Here’s What to Know

Bad Bunny Meets Public Health; Docs Are the Worst Patients; When Ortho Runs Rounds

Potentially Blinding Eye Condition Tied to Ozempic Again

FDA Approves Wearable Device to Treat Pancreatic Cancer

Is One Salvage Strategy Best in Localized Prostate Cancer?

Safety of Crohn’s Disease Meds; Boosting CRC Screening; BMI and Liver Risks

EPA Revokes Finding That Helped Fight Climate Change: Here’s What to Know

Bad Bunny Meets Public Health; Docs Are the Worst Patients; When Ortho Runs Rounds

Potentially Blinding Eye Condition Tied to Ozempic Again

FDA Approves Wearable Device to Treat Pancreatic Cancer

Is One Salvage Strategy Best in Localized Prostate Cancer?

Safety of Crohn’s Disease Meds; Boosting CRC Screening; BMI and Liver Risks

The EPA Just Made Our Air Less Safe to Breathe

No Link Between COVID Shot in Pregnancy and Kids’ Autism Symptoms

Categories

Archives